14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of MDWD
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Green day on Friday for MediWound Ltd.
(Updated on Oct 04, 2024)

Sell candidate since Oct 01, 2024 Loss -1.42%

The MediWound Ltd. stock price gained 0.784% on the last trading day (Friday, 4th Oct 2024), rising from $16.59 to $16.72. During the last trading day the stock fluctuated 3.05% from a day low at $16.56 to a day high of $17.07. The price has fallen in 7 of the last 10 days and is down by -4.89% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 27 thousand shares were bought and sold for approximately $444.05 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.81% during the next 3 months and, with a 90% probability hold a price between $12.35 and $16.23 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

MDWD Signals & Forecast

There are mixed signals in the stock today. The MediWound Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $17.06 and $17.77. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Thursday, October 03, 2024, and so far it has risen 0.784%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). MediWound Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for MediWound Ltd. stock

MediWound Ltd. finds support from accumulated volume at $16.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.505 between high and low, or 3.05%. For the last week, the stock has had daily average volatility of 4.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MDWD) For The Upcoming Trading Day Of Monday 7th

For the upcoming trading day on Monday, 7th we expect MediWound Ltd. to open at $16.78, and during the day (based on 14 day Average True Range), to move between $15.92 and $17.52, which gives a possible trading interval of +/-$0.795 (+/-4.76%) up or down from last closing price. If MediWound Ltd. takes out the full calculated possible swing range there will be an estimated 9.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $16.60 (0.72%) than the resistance at $19.36 (15.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MediWound Ltd. stock A Buy?

MediWound Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.862 Sell Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on October 7, 2024 - $16.78 ( 0.369%). The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MDWD

Fibonacci Support & Resistance Levels

Level Price
R3 17.29 3.39%
R2 17.09 2.24%
R1 16.97 1.52%
Price 16.72
S1 16.59 -0.785%
S2 16.47 -1.50%
S3 16.28 -2.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 20.10 20.22%
R2 19.60 17.22%
R1 19.36 15.79%
Price 16.72
S1 16.60 -0.718%
S2 16.59 -0.778%
S3 16.35 -2.21%

FAQ

What is the symbol for MediWound Ltd. Stock and on which exchange is it traded?
The symbol for MediWound Ltd. is MDWD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MediWound Ltd. Stock?
MediWound Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy MediWound Ltd. Stock?
MediWound Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MediWound Ltd. Stock.

What's the current price of MediWound Ltd. Stock?
As of the end of day on the Oct 04, 2024, the price of an MediWound Ltd. (MDWD) share was $16.72.

What is the 52-week high and low for MediWound Ltd. Stock?
The 52-week high for MediWound Ltd. Stock is $24.00 and the 52-week low is $7.45.

What is the market capitalization of MediWound Ltd. Stock?
As of the Oct 04, 2024, the market capitalization of MediWound Ltd. is 180.349M.

When is the next earnings date for MediWound Ltd.?
The upcoming earnings date for MediWound Ltd. is Nov 19, 2024.
Click to get the best stock tips daily for free!
ABOUT MEDIWOUND LTD.
MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for ...
GOLDEN STAR
Ticker Change Signal Date
WM
$207.93
0.558% Oct 01
VET
$9.77
7.06% Sep 30
FSK
$19.73
1.57% Sep 30
XOM
$115.82
5.84% Sep 27
HES
$133.61
5.43% Sep 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE